Gabor patch technology is a non-invasive, patient-specific treatment based on visual stimulation and facilitation of neural connections responsible for vision. The treatment improved BCVA in Stargardt patients. Mean BCVA, for the 10 eyes, has raised from 0.81 (+- 0.17) logMar to 0.49 (+-0.07) logMar. Mean ETDRS’ chart lines improvement has been 3.18 +-2.05. This improvement appears to be retained for at least 12 months after treatment, consistent with the disease progression.
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study
Gallenga CE
Primo
Conceptualization
;Parmeggiani FSecondo
Validation
;Perri P.Ultimo
Supervision
2018
Abstract
Gabor patch technology is a non-invasive, patient-specific treatment based on visual stimulation and facilitation of neural connections responsible for vision. The treatment improved BCVA in Stargardt patients. Mean BCVA, for the 10 eyes, has raised from 0.81 (+- 0.17) logMar to 0.49 (+-0.07) logMar. Mean ETDRS’ chart lines improvement has been 3.18 +-2.05. This improvement appears to be retained for at least 12 months after treatment, consistent with the disease progression.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ECOP-09-00273.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Post-print
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
611.32 kB
Formato
Adobe PDF
|
611.32 kB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
